Abiomed, Inc.ABMDNASDAQ
Loading
EV to Sales HistoryNormalizing
Percentile Rank79
3Y CAGR-3.4%
5Y CAGR+3.6%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-3.4%/yr
vs +6.4%/yr prior
5Y CAGR
+3.6%/yr
Recent deceleration
Acceleration
-9.8pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
202214.46-13.4%
202116.70+120.6%
20207.57-52.8%
201916.06-25.6%
201821.57+78.2%
201712.11+0.9%
201612.00-4.3%
201512.53+129.4%
20145.46+22.3%
20134.47-